Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16
达雷妥尤单抗、环磷酰胺、硼替佐米和地塞米松治疗不适合移植的多发性骨髓瘤：AMaRC 03-16
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023012539
Mollee, Peter; Reynolds, John; Janowski, Wojt; Quach, Hang; Campbell, Philip; Gibbs, Simon; Lee, Sophie; Lee, Edwin; Taylor, Kerry; Cochrane, Tara; Wallington-Gates, Craig; Kwok, Fiona; Weber, Nicholas; Kerridge, Ian; Weston, Helen; Ho, P Joy; Leahy, Michael Francis; Horvath, Noemi; Spencer, Andrew
